|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A recombinant vaccinia virus encoding human papillomavirus types 16 and 18,E6and E7 proteins as immunotherapy for cervical Cancer显示文摘 | Borysiewicz LK Fiander A Nimako M | | 0，，9014： | 1 |
| 2 | A recombinant vaccinia virus encoding human papillomavirus type 16 and 18,E6 and E7 proteins as immmunotherapy for cervical cancer显示文摘 | LK Borysiewicz A Fiander M Nimako | 1996 | LANET1996，347，11： | 1 |
| 3 | A recombinant vaccinia virus encoding human papillomavirus types 16 and 18,E6 and E7 proteins as immunotherapy for cervical cancer显示文摘 | Fiande A Nimakeo M | 1996 | Lancet1996，347，9014： | 1 |
| 4 | A recombinant vaceinia virus encoding human papillomavirus type 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer 显示文摘 | Borysiewicz LK Fiander A Nimako M | 1996 | Lancet1996，347，9014： | 1 |
| 5 | Human cytomegalovirus pp65-and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens显示文摘 | Tabi Z Moutaftsi M Borysiewicz LK | 2001 | J Immunol2001，166，9： | 1 |
| 6 | Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6显示文摘 | Evans M Borysiewicz LK Evans AS | 2001 | J Immunol2001，167，9： | 1 |
| 7 | A recombinant vaccinia virus encoding human papillomavirus types 16 and 18,E6 and E7 proteins as immunotherapy for cervical cancer显示文摘 | Borysiewicz LK Fiander A Nimako M | 1996 | Gene Ther1996，347，9014： | 1 |
| 8 | Antigen process- ing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6 显示文摘 | Evans M Borysiewicz LK Evans AS | 2001 | J hn- munol2001，167，9： | 1 |
| 9 | A recombinant vaceinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer 显示文摘 | Borysiewicz LK Fiander A Nimako M | 1996 | Lancet1996，347，9014： | 1 |
| 10 | Human cytomegalovirus pp65 and immediate early antigen specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens显示文摘 | Tabi Z Moutaftsi M Borysiewicz LK | 2001 | Immunol2001，166，9： | 1 |
| 11 | Human cytomegalovirus pp65 and immediate early 1 antigen-specific HLA classl-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens 显示文摘 | Tabi Z Moutaftsi M Borysiewicz LK | 2001 | Immunology2001，166，9： | 1 |
| 12 | A recombinant vaccinia virus encoding human papillomavirus types 16 and 18,E6 and E7 proteins as immunotherapy for cervical cancer 显示文摘 | Borysiewicz LK Fiander A Nimako M | 1996 | Lancet1996，347，9014： | 1 |
| 13 | A recombinant vaccinia Virus encoding human types 16 and18,E6 and E7 proteins as immunotherapy for cervical cancer显示文摘 | Fiander A Nimako M | 1996 | Lancet1996，347，9014： | 1 |
| 14 | Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6显示文摘 | Borysiewicz LK Evans AS | 2001 | J Immunol2001，167，9： | 1 |
| 15 | A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer 显示文摘 | Borysiewicz LK Fiander A Nimako M | 1996 | Gene Ther1996，347，： | 1 |
| 16 | Antigen pricessing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomvirus16E6 显示文摘 | Evans M Borysiewicz LK Evans AS | 2001 | Immunol2001，169，9： | 1 |
| 17 | A re- combinant vaccinia virus encoding human papillomavirus type 16 and 18,E6 and E7 proteins as immunotherapy for cervical cancer显示文摘 | BORYSIEWICZ LK FIANDER A NIMAKO M | 1996 | Lancet1996，347，9014： | 1 |
| 18 | Cytomegalovirus:Its cellular immumology and biology显示文摘 | Sissons JGP Borysiewicz LK Rodgers B | 1986 | Immunol Today1986，7，2： | 1 |
| 19 | Prevention is better than cure 显示文摘 | Borysiewicz LK | 2010 | Lancet2010，375，9713： | 1 |
| 20 | Human cytomegalovirus pp 65- and immediate ear]y 1 antigen-specific HLA class I - restricted cytotoxic T cell responses induced by cross-presentation of viral antigens显示文摘 | Tabi Z Moutaftsi M Borysiewicz LK | 2008 | J Immunol2008，166，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员